Yıl: 2021 Cilt: 19 Sayı: 1 Sayfa Aralığı: 6 - 11 Metin Dili: İngilizce DOI: 10.21911/aai.543 İndeks Tarihi: 05-10-2021

Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria

Öz:
Objective: Chronic urticaria (CU), a common disease characterized by itching wheals, leads to a negative effect of on quality of life(QoL). It may cause anxiety and depression or result in exacerbation of these. We aimed to i) evaluate depression, anxiety levels and QoLin patients with CU and compare these with those of controls, ii) show whether there is any correlation between disease activity andQoL, anxiety, and depression.Materials and Methods: A total of 105 CU patients and 86 controls, all above the age of 18 years, were included. Levels of anxiety,depression, and disease activity in patients and controls were measured with the Spielberger State/Trait Anxiety Inventory (STAI-S/T),Beck Depression Inventory (BDI), and Urticaria Activity Score 7 (UAS7). QoL was evaluated with the Dermatology Life Quality Index(DQLI) for CU patients. Data were analyzed with SPSS 24.0. A p-value of less than 0.05 was considered statistically significant.Results: STAI-S showed that the anxiety rate was nearly two-fold in patients with CU compared to the controls (63.4% vs. 35.1%,p=0.001). When BDI scores were categorized, a higher fraction of controls had minimal BDI scores, compared to the patients who hadmoderate to severe depression (75.2% vs. 39%, p=0.0001). A positive, but low-to-moderate correlation was determined between diseaseactivity and impaired QoL (R: 0.448, p: 0.001).Conclusion: Anxiety and depression levels were higher in CU patients. DQLI was low-to-moderately correlated with disease activity;patients with higher disease activity had higher levels of impairment in the quality of life. A psychological pre-assessment and psychiatricconsultation in necessary cases could make a significant improvement in the management of CU.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Saini SS. Urticaria and angioedema. Urticaria and angioedema In: Adkinson Jr N, Bochner B, Burks AW, Busse W, Holgate S, Lemanske R, O’Hehir R (eds), Middleton’s Allergy. Princ Pract, 8th ed., vol. 1–2, Elsevier Inc; 2014:575-87.
  • 2. Bansal CJ, Bansal AS. Stress, pseudoallergens, autoimmunity, infection and inflammation in chronic spontaneous urticaria. Allergy Asthma Clin Immunol 2019;15:56.
  • 3. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy Eur J Allergy Clin Immunol 2018;73:1393-414.
  • 4. Staubach P, Dechene M, Metz M, Magerl M, Siebenhaar F, Weller K, et al. High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol 2011;91:557-61.
  • 5. Gupta M, Gupta A. The use of antidepressant drugs in dermatology. J Eur Acad Dermatology Venereol 2001;15:512-8.
  • 6. Hashiro M. Psychosomatic treatment of a case of chronic urticaria. J Dermatol 1995;22:686-9.
  • 7. Gupta MA, Gupta AK. Chronic idiopathic urticaria and posttraumatic stress disorder (PTSD): An under-recognized comorbidity. Clin Dermatol 2012;30:351-4.
  • 8. Engin B, Uguz F, Yilmaz E, Özdemir M, Mevlitoglu I. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. J Eur Acad Dermatology Venereol 2008;22:36-40.
  • 9. Hisli N. Beck Depresyon Envanterinin gecerliligi uzerine bir calisma (A study on the validity of Beck Depression Inventory). Psikol Dergisi 1988;6:118-22.
  • 10. Beck AT, Steer RA, Brown GK. Beck depression inventory-II. San Antonio 1996;78:490-8.
  • 11. Oner N, LeCompte WA. Durumluk-sürekli kaygı envanteri el kitabı. İstanbul: Boğaziçi Üniversitesi Yayınları, 1985.
  • 12. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken) 2011;63:S467-72.
  • 13. Öztürkcan S, Ermertcan AT, Eser E, Turhan Şahin M. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol 2006;45:1300-7.
  • 14. Hongbo Y, Thomas CL, Harrison MA, Sam Salek M, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 2005;125:659-64.
  • 15. Annesi-Maesano I, Beyer A, Marmouz F, Mathelier-Fusade P, Vervloet D, Bauchau V. Do patients with skin allergies have higher levels of anxiety than patients with allergic respiratory diseases? Results of a large-scale cross-sectional study in a French population. Br J Dermatol 2006;154:1128-36.
  • 16. Pasaoglu G, Bavbek S, Tugcu H, Abadoglu O, Misirligil Z. Psychological status of patients with chronic urticaria. J Dermatol 2006;33:765-71.
  • 17. Konstantinou GN, Konstantinou GN. Psychiatric comorbidity in chronic urticaria patients: A systematic review and metaanalysis. Clin Transl Allergy 2019;9:42.
  • 18. Özkan M, Oflaz SB, Kocaman N, Özşeker F, Gelincik A, Büyüköztürk S, et al. Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2007;99:29-33.
  • 19. Bozo Ö, Demirtepe-Saygılı D, Güneş S, Çenesiz GZ, Baysan A. Does problem focused coping buffer the effects of trait anxiety on depressive symptoms of chronic urticaria patients? J Gen Psychol 2018;145:64-78.
  • 20. Staubach P, Eckhardt-Henn A, Dechene M, Vonend A, Metz M, Magerl M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006;154:294-8.
  • 21. Caffarelli C, Paravati F, El Hachem M, Duse M, Bergamini M, Simeone G, et al. Management of chronic urticaria in children: A clinical guideline. Ital J Pediatr 2019;45:101.
APA EMRE E, Tazegul G (2021). Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. , 6 - 11. 10.21911/aai.543
Chicago EMRE Emre,Tazegul Gokhan Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. (2021): 6 - 11. 10.21911/aai.543
MLA EMRE Emre,Tazegul Gokhan Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. , 2021, ss.6 - 11. 10.21911/aai.543
AMA EMRE E,Tazegul G Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. . 2021; 6 - 11. 10.21911/aai.543
Vancouver EMRE E,Tazegul G Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. . 2021; 6 - 11. 10.21911/aai.543
IEEE EMRE E,Tazegul G "Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria." , ss.6 - 11, 2021. 10.21911/aai.543
ISNAD EMRE, Emre - Tazegul, Gokhan. "Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria". (2021), 6-11. https://doi.org/10.21911/aai.543
APA EMRE E, Tazegul G (2021). Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. Astım Allerji İmmünoloji, 19(1), 6 - 11. 10.21911/aai.543
Chicago EMRE Emre,Tazegul Gokhan Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. Astım Allerji İmmünoloji 19, no.1 (2021): 6 - 11. 10.21911/aai.543
MLA EMRE Emre,Tazegul Gokhan Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. Astım Allerji İmmünoloji, vol.19, no.1, 2021, ss.6 - 11. 10.21911/aai.543
AMA EMRE E,Tazegul G Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. Astım Allerji İmmünoloji. 2021; 19(1): 6 - 11. 10.21911/aai.543
Vancouver EMRE E,Tazegul G Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. Astım Allerji İmmünoloji. 2021; 19(1): 6 - 11. 10.21911/aai.543
IEEE EMRE E,Tazegul G "Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria." Astım Allerji İmmünoloji, 19, ss.6 - 11, 2021. 10.21911/aai.543
ISNAD EMRE, Emre - Tazegul, Gokhan. "Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria". Astım Allerji İmmünoloji 19/1 (2021), 6-11. https://doi.org/10.21911/aai.543